Current Issue 28 August 2012, Vol. 321, No. 2

Issue Highlights

  • Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer
    28 August 2012(Vol. 321 | No. 2 | Pages 101-109)

    Karen L. Reckamp

  • Mucins and Toll-like receptors: Kith and kin in infection and cancer
    28 August 2012(Vol. 321 | No. 2 | Pages 110-119)

    Shikha Tarang, Sushil Kumar, Surinder K. Batra

  • Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells
    28 August 2012(Vol. 321 | No. 2 | Pages 120-127)

    Adnan O. Abu-Yousif, Anne C.E. Moor, Xiang Zheng, Mark D. Savellano, Weiping Yu, Pål K. Selbo, Tayyaba Hasan

  • Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors
    18 May 2012

    Nam-Chul Jung, Hee Jung Kim, Mi-Sun Kang, Jun-Ho Lee, Jie-Young Song, Han Geuk Seo, Yong-Soo Bae, Dae-Seog Lim

  • Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo
    17 May 2012

    Senay Yildirim, Seyhan Altun, Hatice Gumushan, Anup Patel, Mustafa B.A. Djamgoz

  • Statins and cancer: Current and future prospects
    17 May 2012

    Maja Osmak

  • Translating TRAIL-receptor targeting agents to the clinic
    17 May 2012

    Martha W. den Hollander, Jourik A. Gietema, Steven de Jong, Annemiek M.E. Walenkamp, Anna K.L. Reyners, Corina N.A.M. Oldenhuis, Elisabeth G.E. de Vries

  • Epigenetics in human gliomas
    16 May 2012

    Simone Kreth, Niklas Thon, Friedrich W. Kreth

  • View More Articles in Press...

On the Cover


Cover Image

Journal Ranking

Impact Factor: 4.864

Journal Access

Full-text articles are available from 1995 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to:

Activate Online Access

Publishing Information

Cancer Letters is published by Elsevier.


Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Cancer Letters

Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine.

Sponsored Articles

Cancer Letters offers authors or their institutions the option to sponsor non-subscriber access to their articles on Elsevier's electronic publishing platforms. For more information please click here.